ARTICLE | Company News
PharmaMar, TTY Biopharm deal
September 7, 2015 7:00 AM UTC
PharmaMar granted TTY exclusive rights to develop and commercialize Aplidin plitidepsin in Taiwan. The marine-derived VEGF inhibitor is in a Phase III trial to treat relapsed or refractory multiple m...